Reagila 1.5 mg
Reagila 1.5 mg is a medicine authorised by Swissmedic under authorisation number 66364. The authorisation holder is RECORDATI AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 19 June 2018 and the authorisation is valid without a time limit. ATC code N05AX15 places the medicine in the group Psycholeptics.
| Authorisation number | 66364 |
|---|---|
| Name | Reagila 1.5 mg |
| Full name | Reagila 1.5 mg, Hartkapseln |
| Authorisation holder | RECORDATI AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | N05AX15 |
| First authorisation | 19 June 2018 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Reagila 1.5 mg, Hartkapseln | B | 19 June 2018 |
| 2 | Reagila 3 mg, Hartkapseln | B | 19 June 2018 |
| 3 | Reagila 4.5 mg, Hartkapseln | B | 19 June 2018 |
| 4 | Reagila 6 mg, Hartkapseln | B | 19 June 2018 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 28 | Kapsel(n) | N05AX15 | 01.05.0. | B |
| 2 | 56 | Kapsel(n) | N05AX15 | 01.05.0. | B |
| 3 | 28 | Kapsel(n) | N05AX15 | 01.05.0. | B |
| 4 | 56 | Kapsel(n) | N05AX15 | 01.05.0. | B |
| 5 | 28 | Kapsel(n) | N05AX15 | 01.05.0. | B |
| 6 | 56 | Kapsel(n) | N05AX15 | 01.05.0. | B |
| 7 | 28 | Kapsel(n) | N05AX15 | 01.05.0. | B |
| 8 | 56 | Kapsel(n) | N05AX15 | 01.05.0. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Reagila 1.5 mg authorised in Switzerland?
Yes. Reagila 1.5 mg is authorised by Swissmedic under authorisation number 66364, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Reagila 1.5 mg have?
Reagila 1.5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Reagila 1.5 mg?
The authorisation holder is RECORDATI AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.